A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience
Authors:
Open Access
- 1 January 2013
- journal article
- Published by The Korean Association for the Study of the Liver in Clinical and Molecular Hepatology
- Vol. 19 (1) , 51-59
Abstract
Oh MJ, et al. Clin Mol Hepatol. 2013 Mar;19(1):51-59. http://dx.doi.org/10.3350/cmh.2013.19.1.51Keywords
This publication has 27 references indexed in Scilit:
- Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infectionLiver International, 2010
- Anti-CD20 monoclonal antibodies: historical and future perspectivesHaematologica, 2009
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantationBlood, 2009
- EASL Clinical Practice Guidelines: Management of chronic hepatitis BJournal of Hepatology, 2009
- A review of the current use of rituximab in autoimmune diseasesInternational Immunopharmacology, 2009
- Chronic Hepatitis B — New Goals, New TreatmentNew England Journal of Medicine, 2008
- Kinetics and Risk of De Novo Hepatitis B Infection in HBsAg–Negative Patients Undergoing Cytotoxic ChemotherapyGastroenterology, 2006
- Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapyHepatology, 2006
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997